Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Conditions:   Pancreas Cancer;   Adenocarcinoma Intervention:   Sponsor:   Groupe Hospitalier Paris Saint Joseph Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials